NWS vs TXMD · rev $2.11B vs rev $1.8M
NWS (NWS) versus TherapeuticsMD Inc (TXMD) — a side-by-side from cached financials, not a winner call.
NWS (NWS) common stock.
TherapeuticsMD Inc (TXMD) is a drug manufacturers - specialty & generic company listed on US.
Latest reported NWS revenue for 2025-06-30 was $2.11B. Net income was $743.0M. Revenue was up 0.8% from 2024-06-30 to 2025-06-30. NWS currently screens at market cap $0.
Latest reported TXMD revenue for 2024-12-31 was $1.8M. Net income was -$2.2M. Revenue was up 35.3% from 2023-12-31 to 2024-12-31. TXMD currently screens at market cap $13.7M.
NWS currently screens at market cap $0. TXMD currently screens at market cap $13.7M.
Not investment advice. Open the NWS and TXMD stock pages for the full models.
Not investment advice.